Aldesleukin Completed Phase 3 Trials for Stage IIIC Skin Melanoma / Recurrent Melanoma / Stage IIIB Skin Melanoma / Stage IIIA Skin Melanoma / Stage IV Skin Melanoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00019682Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma